Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era

Liu Yanzhong; Bai Hongwei; Qian Yeyong; Shi Bingyi; Chang Jingyuan; Li Chao; Li Gang; Xie Junjie; Yu Fei

doi:10.3969/j.issn.1674-7445.2020.01.012

Volume 11 Issue 1

Jan. 2020

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2020 > 11(1): 76-81

Liu Yanzhong, Bai Hongwei, Qian Yeyong, et al. Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era[J]. ORGAN TRANSPLANTATION, 2020, 11(1): 76-81. doi: 10.3969/j.issn.1674-7445.2020.01.012

Citation:

PDF( 947 KB)

Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era

doi: 10.3969/j.issn.1674-7445.2020.01.012

Second Department of Urology, the Eighth Medical Center of Chinese PLA General Hospital, Beijing 100091, China

More Information

Corresponding author: Bai Hongwei, Email:baihongwei99@163.com
Received Date: 2019-10-17
Available Online: 2021-01-19
Publish Date: 2020-01-15

Abstract

Abstract

Objective To summarize the clinical treatment experience of carbapenem-resistant Klebsiella pneumoniae (CRKP) infection after renal transplantation in donation after cardiac death (DCD) era. Methods Clinical data of 10 donors and 17 recipients with CRKP infection after DCD renal transplantation from January 2015 to January 2019 were retrospectively analyzed. Both donors and recipients received bacterial culture and drug sensitivity test. Clinical manifestations, treatment and outcome of CRKP-infected recipients were recorded. Results Seven donors were infected with CRKP. After pretreatment, CRKP in 2 cases turned negative, CRKP in 5 donors did not turn negative. All renal grafts were treated with tigecycline+meropenem+voriconazole lavage to prevent infection. Among 17 recipients with CRKP infection, 11 cases were positive for blood culture, 10 positive for urine culture, 3 positive for sputum culture, 3 positive for incisional secretion and 3 positive for retroperitoneal drainage. Clinical manifestations included fever in 8 cases, rupture and hemorrhage of the transplant renal artery in 7 cases or thrombosis in the transplant renal artery in 1 case, bladder irritation sign in 3 cases and cough with brick red jelly-like sputum in 1 case, respectively. Five patients were treated with tigecycline+meropenem, 1 patient suffered from renal graft loss and 4 recipients died. Twelve patients were treated with ceftazidime-avibactam +meropenem, 3 patients presented with renal graft loss and 1 recipient died. Conclusions CRKP-infected donor is not the absolute contraindication of renal transplantation. Pretreatment of donor infection and early administration of sufficient sensitive antibiotics can cure CRKP infection and improve the clinical prognosis of renal transplant recipients.
- Renal transplantation,
- Carbapenem-resistant Klebsiella pneumoniae,
- Donation after cardiac death,
- Bacterial culture,
- Donor-derived infection,
- Drug-resistant bacterial infection,
- Tigecycline,
- Meropenem,
- Avibactam

FullText(HTML)

References(24)

References

[1]	XU L, SUN X, MA X. Systematic review and Meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae[J]. Ann Clin Microbiol Antimicrob, 2017, 16(1):18. DOI: 10.1186/s12941-017-0191-3.
[2]	YIGIT H, QUEENAN AM, ANDERSON GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2001, 45(4):1151-1161. doi: 10.1128/AAC.45.4.1151-1161.2001
[3]	范鹏飞, 张玮晔.心脏死亡器官捐献供肝功能维护的研究进展[J/CD].实用器官移植电子杂志, 2016, 4(5): 311-314. DOI: 10.3969/j.issn.2095-5332.2016.05.012. FAN PF, ZHANG WY. Research progress on the maintenance of liver function from cardiac death organ donation[J/CD]. Pract J Organ Transplant (Electr Vers), 2016, 4(5): 311-314. DOI: 10.3969/j.issn.2095-5332.2016.05.012.
[4]	HU FP, GUO Y, ZHU DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014[J]. Clin Microbiol Infect, 2016, 22(Suppl 1):S9-S14. DOI: 10.1016/j.cmi.2016.01.001.
[5]	李智斌, 张更, 刘克普, 等.公民逝世后器官捐献肾移植早期多重耐药菌感染的临床研究[J].器官移植, 2017, 8(5):386-391. DOI: 10.3969/j.issn.1674-7445.2017.05.010. LI ZB, ZHANG G, LIU KP, et al. Clinical study of early infection of multi-drug resistant organisms after renal transplantation from organ donation after citizen's death[J]. Organ Transplant, 2017, 8(5):386-391. DOI: 10.3969/j.issn.1674-7445.2017.05.010.
[6]	王长希, 邓荣海.公民逝世后器官捐献感染性供者的移植应用[J/CD].中华移植杂志(电子版), 2016, 10(1): 24-28.DOI: 10.3877/cma.j.issn.1674-3903.2016.01.004. WANG CX, DENG RH. Organ transplantation of infected donors derived from donation after citizen death[J/CD]. Chin J Transplant (Electr Vers), 2016, 10(1): 24-28. DOI: 10.3877/cma.j.issn.1674-3903.2016.01.004.
[7]	许名杰, 谢续标, 彭龙开, 等.肾移植后感染性移植肾动脉破裂五例临床分析[J].中华器官移植杂志, 2017, 38(4):211-217.DOI:10.3760/cma.j.issn.0254-1785. 2017.04.004. XU MJ, XIE XB, PENG LK, et al. Clinical analysis of 5 cases of infectious renal artery rupture after renal transplantation[J]. Chin J Organ Transplant, 2017, 38(4):211-217. DOI: 10.3760/cma.j.issn.0254-1785.2017.04.004.
[8]	王全楚, 朱晓红, 唐中雷.高致病性肺炎克雷伯杆菌导致的社区获得性肺炎死亡1例[J].中华危重病急救医学, 2017, 29(1):84.DOI:10.3760/cma.j.issn.2095-4352. 2017.01.018. WANG QC, ZHU XH, TANG ZL. A dead case of severe community-acquired pneumonia caused by highly pathogenic Klebsiella pneumoniae[J]. Chin Crit Care Med, 2017, 29(1):84. DOI:10.3760/cma.j.issn.2095-4352. 2017.01.018.
[9]	韩环立, 张明满, 郭春宝, 等.胆道闭锁患儿肝移植术后并发症分析[J].临床肝胆病杂志, 2017, 33(2):316-319. DOI: 10.3969/j.issn.1001-5256.2017.02.024. HAN HL, ZHANG MM, GUO CB, et al. An analysisof postoperative complications in children with biliaryatresia after liver transplantation[J]. J Clin Hepatol, 2017, 33(2):316-319. DOI: 10.3969/j.issn.1001-5256.2017.02.024.
[10]	LEWIS JD, SIFRI CD. Multidrug-resistant bacterial donor-derived infections in solid organ transplantation[J]. Curr Infect Dis Rep, 2016, 18(6):18. DOI: 10.1007/s11908-016-0526-9.
[11]	张鹏亮, 徐修礼, 白露.医院感染大肠埃希菌及肺炎克雷伯菌的产酶率与耐药性分析[J].中华医院感染学杂志, 2015, 23(3):508-510.DOI: 10.11816/cn.ni.2015-124964. ZHANG PL, XU XL, BAI L. Analysis of drug resistance and enzyme production rate of Escherichia coli and Klebsiella pneumoniae in hospital infections[J]. ChinJ Nosocom, 2015, 23(3):508-510. DOI: 10.11816/cn.ni.2015-124964.
[12]	李凤林, 马振广, 夏红强.肺炎克雷伯杆菌致血流感染1例分析[J].实用检验医师杂志, 2016, 8(3):188-190. DOI: 10.3969/j.issn.1674-7151.2016.03.019. LI FL, MA ZG, XIA HQ. Analysis of 1 case of bloodstream infection caused by Klebsiella pneumoniae[J]. Chin JLabor Path, 2016, 8(3):188-190. DOI: 10.3969/j.issn.1674-7151.2016.03.019.
[13]	TAMINATO M, FRAM D, PEREIRA RRF, et al. Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients[J]. Rev Bras Enferm, 2019, 72(3):760-766. DOI: 10.1590/0034-7167-2019-0009.
[14]	BERGAMASCO MD, BARROSO BARBOSA M, DE OLIVEIRA GARCIA D, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation[J]. Transpl Infect Dis, 2012, 14(2):198-205. DOI: 10.1111/j.1399-3062.2011.00688.x.
[15]	唐小红, 朱卫民.肺炎克雷伯菌耐碳青霉烯类抗菌药的研究进展[J].国外医药(抗生素分册), 2014, 35(3):115-118, 122.DOI: 10.3969/j.issn.1001-8751.2014.03.004. TANG XH, ZHU WM. Progress about carbapenem resistant of Klebsiella pneumoniae[J]. World Not Antibio, 2014, 35(3):115-118, 122.DOI:10.3969/j.issn. 1001-8751.2014.03.004.
[16]	HIRSCH EB, TAM VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection[J]. J Antimicrob Chemother, 2010, 65(6):1119-1125. DOI: 10.1093/jac/dkq108.
[17]	CICORA F, MOS F, ROBERTI J. Kidney transplant recipients infected with blaKPC-2-producing Klebsiella pneumoniae[J]. Nefrologia, 2015, 35(3):340-343. DOI: 10.1016/j.nefro.2015.02.002.
[18]	DENG M, ZHU MH, LI JJ, et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of acinetobacter baumannii from a Chinese university hospital[J]. Antimicrob Agents Chemother, 2014, 58(1):297-303. DOI: 10.1128/AAC.01727-13.
[19]	SPANU T, DE ANGELIS G, CIPRIANI M, et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli[J]. Antimicrob Agents Chemother, 2012, 56(8):4516-4518. DOI: 10.1128/AAC.00234-12.
[20]	LEVASSEUR P, GIRARD AM, CLAUDON M, et al. In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates[J]. Antimicrob Agents Chemother, 2012, 56(3):1606-1608. DOI: 10.1128/AAC.06064-11.
[21]	曾志旋, 曹胜华, 陈林.新型β-内酰胺酶抑制剂——阿维巴坦的研究进展[J].国外医药(抗生素分册), 2014, 35(2):58-62.DOI: 10.3969/j.issn.1001-8751.2014.02.002. ZENG ZX, CAO SH, CHEN L. The research advance of a novel β-lactamase inhibitor—avibactam[J]. World Not Antibio, 2014, 35(2):58-62. DOI:10.3969/j.issn.1001- 8751.2014.02.002.
[22]	LAGACÉ-WIENS P, WALKTY A, KARLOWSKY JA. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections[J]. Core Evid, 2014, 9:13-25. DOI: 10.2147/CE.S40698.
[23]	CASTANHEIRA M, MENDES RE, SADER HS. Low frequency of ceftazidime-avibactam resistance among enterobacteriaceae isolates carrying blaKPC collected in U.S. hospitals from 2012 to 2015[J]. Antimicrob Agents Chemother, 2017, 61(3): e02369-16. DOI: 10.1128/AAC. 02369-16.
[24]	YANG M, GAO H, WANG X, et al. Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection: case report[J]. Medicine (Baltimore), 2019, 98(39):e17339. DOI: 10.1097/MD.0000000000017339.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (201) PDF downloads(31)

Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era

doi: 10.3969/j.issn.1674-7445.2020.01.012

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era

doi: 10.3969/j.issn.1674-7445.2020.01.012

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content